Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Other Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00005660
What this trial is testing

The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases

Who this might be right for
Basal Cell CarcinomaKeratosis Palmaris et PlantarisPsoriasis
National Cancer Institute (NCI) 130
Testing effectiveness (Phase 2)Looking for participantsNCT07286149
What this trial is testing

A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)

Who this might be right for
Lung Neoplasm Malignant
Merck Sharp & Dohme LLC 140
Testing effectiveness (Phase 2)Active Not RecruitingNCT01989585
What this trial is testing

Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Malignant Solid Neoplasm+2 more
National Cancer Institute (NCI) 75
Not applicableNo Longer AvailableNCT02197650
What this trial is testing

Expanded Access Program: Safety of Erythrocytes Encapsulating L-asparaginase (GRASPA®) in Combination With Polychemotherapy in Patients Under 55 Years Old With Acute Lymphoblastic Leukemia (ALL) at Risk to Receive Other Formulation of Asparaginase

Who this might be right for
Acute Lymphoblastic Leukemia
ERYtech Pharma
Testing effectiveness (Phase 2)UnknownNCT05019794
What this trial is testing

Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterations

Who this might be right for
Gastric CancerGastroesophageal Junction AdenocarcinomaSolid Tumor
LianBio LLC 80
Testing effectiveness (Phase 2)Looking for participantsNCT04591002
What this trial is testing

Osimertinib to Suppress the Progression of GGN(EGFR Mutation-positive)

Who this might be right for
Lung Cancer
Samsung Medical Center 43
Not applicableUnknownNCT06284980
What this trial is testing

Gestional Trophoblastic Neoplasia Ultrasound Assessment: Titanium Study

Who this might be right for
Describe Typical Gray Scale/Color Doppler Ultrasound Features of Gestational Trophoblastic Neoplasia at the US ExaminationTo Assess if There Are Differences at the Baseline US Scan Between Low-risk and High-risk PatientsTo Identify Ultrasound Predictors of Resistance to First-line Single Drug Chemotherapy in Low-risk GTN Patients+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not applicableStudy completedNCT02540850
What this trial is testing

CRC Screening Using mSEPT9 (Methylated Septin 9) in Chinese Population

Who this might be right for
Colorectal CancerAdenomatous Polyp of ColonPolyps+2 more
BioChain (Beijing) Science and Technology, Inc. 1,031
Early research (Phase 1)Not Yet RecruitingNCT06755242
What this trial is testing

GNC-077 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

Who this might be right for
Gastrointestinal TumorsSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 20
Testing effectiveness (Phase 2)Looking for participantsNCT04683679
What this trial is testing

Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerTNBC - Triple-Negative Breast CancerBreast Cancer+1 more
Memorial Sloan Kettering Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT00634179
What this trial is testing

A Phase I/II Trial of VR-CHOP in Lymphoma Patients

Who this might be right for
Lymphoma, B-CellFollicular Lymphoma
Emory University 37
Early research (Phase 1)Study completedNCT00927966
What this trial is testing

RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms

Who this might be right for
SarcomaSolid Tumor
Suzanne George, MD 21
Early research (Phase 1)UnknownNCT01107522
What this trial is testing

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas

Who this might be right for
Solid Tumors, Glioblastoma, Recurrent Malignant Gliomas
Tactical Therapeutics, Inc. 100
Testing effectiveness (Phase 2)Ended earlyNCT00450983
What this trial is testing

Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center 1
Not applicableLooking for participantsNCT00870129
What this trial is testing

Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors

Who this might be right for
Brain CancerGlioma
Memorial Sloan Kettering Cancer Center 135
Not applicableStudy completedNCT04763902
What this trial is testing

Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer

Who this might be right for
Endometrial Neoplasms
University of Utah 39
Not applicableEnded earlyNCT01419574
What this trial is testing

Ultrasound and Other Images of Artery Blockages

Who this might be right for
Atherosclerosis
National Heart, Lung, and Blood Institute (NHLBI) 12
Testing effectiveness (Phase 2)Looking for participantsNCT06922591
What this trial is testing

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

Who this might be right for
PDACPDAC - Pancreatic Ductal AdenocarcinomaNSCLC+5 more
Tango Therapeutics, Inc. 183
Early research (Phase 1)Active Not RecruitingNCT04722146
What this trial is testing

Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 140
Testing effectiveness (Phase 2)Looking for participantsNCT06566079
What this trial is testing

Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

Who this might be right for
Malignant MesotheliomaMetastatic Malignant Solid TumorAdvanced Solid Tumor
InSilico Medicine Hong Kong Limited 160
Next Page
120